Q66FR3 AF NFT

UDP-N-acetylenolpyruvoylglucosamine reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigepfocli5ljsd5rswfug2xyh7lulsggcxhogqlqdhjw3oh7mxccq/metadata.json
IPFS of structure file: 
bafybeiddohpzzae24olbdayjzwsx4ahuwfzbdh7eupccjd3jjbu2ah3lxe/AF-Q66FR3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x100609714B35e7372d137b552e2e7d843682FA31
First NFT owner address (bech32): 
genesis1zqrqju2txhnnwtgn0d2jutnassmg9733qlsflc
Current NFT ID #250687 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
250687
Accession (UniProt):
Q66FR3
Name::
UDP-N-acetylenolpyruvoylglucosamine reductase
Experimental Method:
Predicted structure
Sequence source:
YERSINIA PSEUDOTUBERCULOSIS SEROTYPE I (STRAIN IP32953)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q66FR3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q66FR3|MURB_YERPS UDP-N-acetylenolpyruvoylglucosamine reductase OS=Yersinia pseudotuberculosis serotype I (strain IP32953) OX=273123 GN=murB PE=3 SV=1 MSNQRSSLKHLNTFALPAYASNVISAGSVETLIAAWHESKAKRQPVLLLGEGSNVLFIKNFSGTVLLNRIMGITSTEDSAAWHLHVGAGENWHQLVCHSLQNNMPGLENLALIPGCVGSAPIQNIGAYGVELKQVCEYVDLLDMDKGTIQRISAEECQFGYRDSIFKHRYGNGFAIVSVGIKLMKSWTPTLGYGDLIHMDPLTVTATDIFNSVCTMRRSKLPDPMVTGNAGSFFKNPVVSAAIAEEIVHCYPNAPHYLQPDGSVKLAAGWLIDQCSLKGYQIGGAAVHQQQALVLINQSEATGQDVIHLARYIRQQVAQRFSIWLEPEVRFIADNGEVNAVEHLS